People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive ...

Despite conflicting data regarding the pharmacological management of Borderline Personality Disorder (BPD), a recent ...

When I shared my bipolar recovery story, many mental health providers doubted that this was possible. Here's how I did ...

People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.

Celebrities who have opened up about their bipolar diagnosis remind us that no matter how privileged a life may seem, ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, ...

Rhea Chakraborty posted the episode of her upcoming show as she discussed the toughest phase of Yo Yo Honey Singh battling bipolar disorder. Check it out.

BRITISH actor and comedian Tony Slattery has died at the age of 65. His family revealed the cause of his death was a heart ...

Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve overall quality of life. Learn more about the medication types, dosage, side ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

If approved, CAPLYTA ® has the potential to be the first treatment approved for MDD and depressive symptoms associated with bipolar I and II in more than 15 years. Additional Phase 3 trials are ...